Coronavirus Disease (COvid-)19 REgistry on THROMBOSIS Complications

NCT ID: NCT04780295

Last Updated: 2023-01-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2708 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-15

Study Completion Date

2021-05-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This online-based, observational retrospective registry aims to (i) study the rate of cardiovascular events, encompassing venous thromboembolic and arterial events, in consecutive hospitalized patients with coronavirus (Covid19), (ii) investigate the prevalent use of thromboprophylaxis, (iii) describe the use of imaging tests for the detection of cardiovascular events in patients with Covid19. This will also facilitate and constitute the basis for the conduction of interventional thromboprophylaxis studies in patients with Covid19.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Hospitalized patients aged ≥ 18 years with a positive test for severe acute respiratory syndrome corona virus 2 (SARS-CoV2)

Exclusion Criteria

None
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Zurich

OTHER

Sponsor Role collaborator

Johannes Gutenberg University Mainz

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof. Stavros Konstantinides, MD

Prof Stavros Konstantinides, MD, Medical Director of the

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stavros Konstantinides, MD, Prof

Role: STUDY_CHAIR

University Medical Center Mainz, Johannes Gutenberg University Mainz

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Unicamp (Universidade Estadual de Campinas; University of Campinas)

Campinas, , Brazil

Site Status

Hospital Sírio-Libanês

São Paulo, , Brazil

Site Status

Hospital de Campanha Anhembi

São Paulo, , Brazil

Site Status

Amager and Hvidovre Hospital

Hvidovre, , Denmark

Site Status

Universitätsklinikum Koeln

Cologne, , Germany

Site Status

Augusta-Krankenhaus Duesseldorf

Düsseldorf, , Germany

Site Status

Universitäts-Herzzentrum Freiburg

Freiburg im Breisgau, , Germany

Site Status

Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes

Homburg, , Germany

Site Status

DRK Kliniken Berlin Köpenick

Köpenick, , Germany

Site Status

Universitätsmedizin Mainz

Mainz, , Germany

Site Status

Krankenhaus Neuwittelsbach

Munich, , Germany

Site Status

Paracelsus Medizinische Privatuniversität am Klinikum Nuernberg

Nuremberg, , Germany

Site Status

DRK Kliniken Berlin Westend

Westend, , Germany

Site Status

Mater Misericordiae University Hospital

Dublin, , Ireland

Site Status

University of Bologna

Bologna, , Italy

Site Status

Azienda Socio Sanitaria Territoriale (ASST) Lariana

Como, , Italy

Site Status

Ospedale Sacra Famiglia Fatebenefratelli

Erba, , Italy

Site Status

Presidio Ospedaliero Santa Croce di Fano

Fano, , Italy

Site Status

IRCCS Ospedale Policlinico San Martino

Genova, , Italy

Site Status

Ospedale Civile di Guastalla - Azienda Unità Sanitaria Locale (AUSL) Reggio Emilia

Guastalla, , Italy

Site Status

Azienda Ospedaliera di Padova

Padua, , Italy

Site Status

Ospedale Maggiore di Parma - Azienda Ospedaliero Universitaria di Parma

Parma, , Italy

Site Status

Fondazione IRCCS Policlinico San Matteo

Pavia, , Italy

Site Status

Ospedale Civile di Castel San Giovanni - Azienda Unità Sanitaria Locale (AUSL) di Piacenza

Piacenza, , Italy

Site Status

Santa Maria Nuova Hospital - Azienda Unità Sanitaria Locale (AUSL) IRCCS di Reggio Emilia

Reggio Emilia, , Italy

Site Status

IRCCS Humanitas Clinical and Research Hospital

Rozzano, , Italy

Site Status

Università degli studi dell' Insubria (University of Insubria)

Varese, , Italy

Site Status

Instituto Nacional de Cardiologia Ignacio Chavez (National Institute of Cardiology Igancio Chavez)

Mexico City, , Mexico

Site Status

Hospital Quirónsalud

Málaga, , Spain

Site Status

Erdem Medical Center

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil Denmark Germany Ireland Italy Mexico Spain Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DRKS00022277

Identifier Type: REGISTRY

Identifier Source: secondary_id

CTH C010

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.